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Abstract 25 
Aim: 26 
Experiments have indicated that skin perfusion in mice is sensitive to reductions in environmental O2 27 
availability. Specifically, a reduction in skin-surface PO2 attenuates transcutaneous O2 diffusion, and 28 
hence epidermal O2 supply. In response, epidermal HIF-1α expression increases and facilitates initial 29 
cutaneous vasoconstriction and subsequent nitric oxide-dependent vasodilation. Here, we investigated 30 
whether the same mechanism exists in humans. 31 
 32 
Methods: 33 
In a first experiment, eight males rested twice for eight hours in a hypobaric chamber. Once, barometric 34 
pressure was reduced by 50%, while systemic oxygenation was preserved by O2-enriched (42%) 35 
breathing gas (HypoxiaSkin), and once barometric pressure and inspired O2 fraction were normal 36 
(Control1). In a second experiment, nine males rested for eight hours with both forearms wrapped in 37 
plastic bags. O2 was expelled from one bag by nitrogen flushing (AnoxiaSkin), whereas the other bag was 38 
flushed with air (Control2). In both experiments, skin blood flux was assessed by laser Doppler on the 39 
dorsal forearm, and HIF-1α expression was determined by immunohistochemical staining in forearm 40 
skin biopsies. 41 
 42 
Results: 43 
Skin blood flux during HypoxiaSkin and AnoxiaSkin remained similar to the corresponding Control trial 44 
(p=0.67 and p=0.81). Immunohistochemically stained epidermal HIF-1α was detected on 8.2±6.1 and 45 
5.3±5.7% of the analyzed area during HypoxiaSkin and Control1 (p=0.30) and on 2.3±1.8 and 2.4±1.8% 46 
during AnoxiaSkin and Control2 (p=0.90), respectively. 47 
 48 
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Conclusion: 49 
Reductions in skin-surface PO2 do not affect skin perfusion in humans. The unchanged epidermal HIF-1α 50 
expression suggests that epidermal O2 homeostasis was not disturbed by HypoxiaSkin/AnoxiaSkin, 51 
potentially due to compensatory increases in arterial O2 extraction. 52 
 53 
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Introduction 56 
Systemic hypoxia induces mild vasodilation in the non-glabrous skin of humans (Leuenberger et al., 57 
1999, Minson, 2003, Simmons et al., 2007, Weisbrod et al., 2001). In hypoxic environments, this effect 58 
may be modified by a direct vasomotor response to the reduced oxygen tension (PO2) on the skin-59 
surface. The O2 demand of the human skin to a depth of ~0.4 mm is almost exclusively covered by 60 
transcutaneous O2 diffusion, which is driven by the transcutaneous PO2 gradient and hence decreases in 61 
hypoxic environments (Stucker et al., 2002). In mice, the resulting reduction in O2 supply to epidermal 62 
cells seems to facilitate the stabilization of hypoxia inducible factor-1α (HIF-1α) (Boutin et al., 2008, 63 
Hamanaka et al., 2016). Epidermal HIF-1α, in turn, appears to induce a bipartite cutaneous vasomotor 64 
response, consisting of initial vasoconstriction and subsequent nitric oxide (NO)-mediated vasodilation. 65 
In the animal model, the resulting changes in skin blood flow had important systemic implications since 66 
they influenced arterial pressure, and modulated the erythropoietin response to systemic hypoxia by 67 
channeling arterial O2 delivery first towards, and then away from kidneys and liver (Boutin et al., 2008). 68 
Whether a reduction in skin-surface PO2 has a similar effect on skin perfusion in humans is barely 69 
explored. Rasmussen et al. (2012) observed similar increases in skin blood flow during either exposure 70 
to hypobaric hypoxia or inhalation of a hypoxic gas mixture through a mouthpiece, i.e. with a normoxic 71 
PO2 on the skin-surface. Nevertheless, systemic hypoxia facilitated pronounced (~ 120 %) increases in 72 
skin blood flow in both conditions, which could have masked a vasomotor response to the reduced skin-73 
surface PO2 in hypobaric hypoxia. 74 
In the present study, we aimed to isolate a potential skin blood flow response to reductions in skin-75 
surface PO2 from the cutaneous vasodilatory effect of systemic hypoxia. Two experiments were 76 
conducted: In the first experiment, eight subjects were exposed for eight hours to hypobaric hypoxia, 77 
while the inspired O2 fraction was increased to preserve systemic oxygenation (HypoxiaSkin). Based on 78 
animal experiments (Boutin et al., 2008), we hypothesized HypoxiaSkin to first reduce and subsequently 79 
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increase skin blood flow. We further expected this response to be accompanied by increased epidermal 80 
HIF-1α expression and, in the later phase of exposure, circulating NO. In the second experiment, we 81 
increased the stimulus by exposing one forearm of nine subjects for eight hours to anoxia (AnoxiaSkin). 82 
Again, we hypothesized AnoxiaSkin to first reduce and subsequently increase skin blood flow as well as 83 
enhance epidermal HIF-1α expression. 84 
  85 
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Materials and Methods 86 
This study was approved by the Human Ethics Committee of Stockholm (ref 2015-315-31-4) and 87 
conducted in accordance with the declaration of Helsinki. 88 
 89 
Subjects 90 
Eight healthy males (27 ± 8 yrs, 182 ± 8 cm, 76.1 ±7.8 kg) were included as study subjects in the 91 
HypoxiaSkin experiment, and nine healthy males (28 ± 5 yrs, 183 ± 5 cm, 87.9 ± 16.2 kg) in the AnoxiaSkin 92 
experiment. All subjects gave written informed consent to participation. None had travelled to altitudes 93 
> 1,000 m during the four weeks preceding the experiments. 94 
 95 
HypoxiaSkin experiment 96 
The protocol of the HypoxiaSkin study is summarized in figure 1. Subjects reported to the laboratory on 97 
two days, separated by at least one week, wearing a short-sleeved T-shirt and shorts. After insertion of a 98 
catheter into an antecubital vein, subjects were placed semi-recumbent in a hypobaric chamber, in 99 
which ambient air was controlled at thermoneutral temperature (~ 27° C). Following instrumentation (~ 100 
20 min), baseline measurements of the variables specified below were performed. Thereafter, the 101 
barometric pressure was, on one day, reduced by ~ 50 % (to 380 mmHg, corresponding to ~ 5,500 m 102 
altitude) for Hypoxiaskin, and maintained on the other day (Control1). The order of HypoxiaSkin and 103 
Control1 was randomized between subjects. To blind the subjects, barometric pressure was repeatedly 104 
slightly increased and decreased at the onset of both trials. Subjects wore a face mask that was 105 
connected on the inspiratory side to a Douglas bag. During HypoxiaSkin, this Douglas bag was filled with a 106 
hyperoxic gas mixture (42 % O2 in N2) so that inspired PO2 remained normal. During Control1 the Douglas 107 
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bag was filled with normal air. Both breathing gases were bubbled through a water container for 108 
humidification before entering the Douglas bag. Throughout both trials, capillary oxyhaemoglobin 109 
saturation was continuously monitored by pulse oximetry (Radical-7, Masimo, Irvine, CA, USA) on the 110 
subjects’ earlobes. 111 
When the final barometric pressure was reached, subjects remained still in the semi-recumbent position 112 
for eight hours, while watching movies. To assess the efficiency of the blinding process, they filled out a 113 
questionnaire immediately after the final barometric pressure was reached, as well as after four and 114 
eight hours of exposure, reporting whether they believed that barometric pressure was reduced or not. 115 
After four hours, a sandwich was provided. To avoid inspiration of chamber air, subjects removed the 116 
masks only to take a bite and put it back on for chewing and swallowing. Drinking water was provided ad 117 
libitum throughout the day employing the same mask procedure. 118 
After eight hours, a circular skin biopsy with a diameter of 3 mm was obtained under local anesthesia (1 119 
% lidocaine) from the dorsal forearm, using a biopsy punch (Miltex Inc., York, PA, USA). Samples were 120 
mounted in an embedding compound (Tissue-Tek O.C.T., Sakura Finetek, Alphen aan den Rijn, the 121 
Netherlands), and immediately frozen on dry ice. Subsequently, the barometric pressure was restored (if 122 
applicable), again, performing repeated increases and decreases in both conditions. 123 
 124 
Measurements 125 
The following measurements were conducted during baseline, after 10 min, and thereafter at every 126 
hour of exposure: Changes in skin blood flux were measured at a rate of 10 Hz on the dorsal side of the 127 
forearm by laser Doppler flowmetry (VMS-LDF2, Moor Instruments, Axminster, UK) using an optic probe 128 
(VP1/7, Moor Instruments). To examine whether HypoxiaSkin differently affects glabrous skin, we also 129 
monitored skin blood flux on the tip of the index finger of the same arm. Due to the variability of the 130 
microvasculature, Laser Doppler assessed skin blood flux depends on the sampling location (Obeid et al., 131 
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1990). Accordingly, the sensors were stabilized with a flexible probe (PH1-V2, Moore) that was firmly 132 
connected to the skin with double-sided adhesive tape and were not moved throughout the entire 133 
exposure. Although only the data collected at the measurement periods specified above were used for 134 
the analysis, skin blood flux was monitored continuously throughout the exposure in order to detect 135 
deteriorations in signal quality. Laser Doppler signal stability over extended periods of continuous 136 
measurement has previously been confirmed (Sundberg, 1984). Both laser Doppler probes were 137 
calibrated before each trial against Brownian motion with a standardized colloidal suspension of 138 
polystyrene microspheres. 139 
Arterial pressure was measured at a sampling rate of 200 Hz using the volume-clamp method 140 
(Finometer PRO, Finapres Medical Systems B.V., Amsterdam, the Netherlands), with the pressure cuff 141 
placed around the middle phalanx of the middle finger, and the reference pressure transducer placed at 142 
the vertical level of the heart. The pressure cuff was removed after each measurement period for 143 
subject comfort and the Finometer re-calibrated at the onset of the next measurement period. 144 
Heart rate was derived from the arterial pressure curves as the inverse of the inter-beat interval. 145 
An index of cardiac stroke volume was determined by a three-element model of arterial input 146 
impedance (Modelflow, Finometer PRO) incorporating age, sex, height, and weight from the arterial 147 
pressure waveform (Wesseling et al., 1993). 148 
Cardiac output was calculated by multiplication of stroke volume with heart rate. 149 
All these measurements were performed over a period of 10 min at each measurement time point 150 
(except after 10 min of exposure, where the measurement period was only 5 min). Unfiltered raw data 151 
was visually inspected for artefacts and then averaged over the respective measurement period for 152 
analysis.  153 
 154 
Venous blood sampling 155 
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During baseline, as well as after one, four and eight hours of exposure, we collected 15 ml of venous 156 
blood. Nitrite (NO2
-) concentration was assessed as a marker for circulating NO (Lauer et al., 2001) by 157 
chemiluminescence (NOA 280i, GE Analytical Instruments, Boulder, CO, USA) in plasma obtained from 158 
these samples. Concentrations of erythropoietin and vascular endothelial growth factor (VEGF), a 159 
recognized HIF-1α target, were quantified in serum by sandwich ELISA (Human Quantikine ELISA kit, 160 
DVE00 and DEP00 respectively, R&D systems, Minneapolis, MN, USA). All samples were assayed in 161 
duplicate by a blinded investigator. The techniques and materials used in this analysis were in 162 
accordance with the protocol provided by the company. Optical density was quantified on a VersaMax 163 
microplate reader using Softmax Pro 6.3 Software (Molecular Devices, Wokingham, UK).  164 
 165 
Epidermal HIF-1α expression 166 
Frozen sections (8 m) of skin biopsies were placed on glass slides and fixed in ice-cold acetone for 10 167 
minutes, followed by incubation with 1 % hydrogen peroxide (H2O2) in phosphate-buffered saline (PBS) 168 
for inactivation of endogenous peroxidase activity. After incubation with PBS containing 3 % bovine 169 
serum albumin (BSA) for 1 h at room temperature, a murine anti-human HIF-1 antibody (NB 100-131, 170 
Novus Biologicals, Littleton, CO, USA) diluted 1:100 in PBS with 1 % BSA was applied to the sections and 171 
incubated over night at 4 C. For negative control stainings, the primary antibody was substituted with 1 172 
% BSA. Resultant antigen-antibody-enzyme complex was visualised using diaminobenzidine (DAB) as 173 
chromogenic substrate for peroxidase. As a control, nuclei were counterstained with haematoxylin. The 174 
sections were mounted with Faramount Aqueous Mounting Medium (DAKO A/S). 40x pictures of dermal 175 
and epidermal regions were taken with an Axio Imager M2 (Zeiss, Oberkochen, Germany), and stained 176 
areas were quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The 177 
stained fraction of the analysed area was used for the quantification of epidermal HIF-1α expression 178 
(Rizzardi et al., 2012, Cowburn et al., 2013). 179 
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 180 
AnoxiaSkin experiment 181 
Subjects reported to the laboratory on one day and were placed in the same position as in the 182 
HypoxiaSkin experiment. They were dressed in shorts and T-shirt, and the room air temperature was 183 
controlled at ~ 27° C. A plastic bag was placed over each forearm with an opening at the bottom at wrist 184 
level, so that the hands were free. The bag was loosely tightened around the arm at elbow and wrist 185 
levels with elastic tape. A small hole was cut into each bag, through which a plastic hose was inserted. 186 
The holes were then sealed around the hose with tape. One hose was connected to a cylinder containing 187 
pure N2 (AnoxiaSkin), and the other to a cylinder containing normal air (Control2). Gas flow from both 188 
cylinders was then started and regulated so that there was a slight overpressure in each bag, with gas 189 
flowing out at the openings at the elbows and wrists. The continuous inflow of N2 rapidly washed out 190 
any residual O2 from the AnoxiaSkin bag, as confirmed on several occasions (Datex Normocap 200 Oxy, 191 
Instrumentarium Corp., Helsinki, Finland). After initiation of the gas flow, subjects remained still while 192 
watching movies. A sandwich was provided after four hours. After eight hours, another hole was cut into 193 
each plastic bag, through which skin biopsies were obtained as described above. During the biopsy 194 
procedure, the gas flow into the bags was increased to prevent inflow of room air. After the biopsies 195 
were obtained, the gas flow was stopped and the plastic bags removed. 196 
 197 
Measurements 198 
In the AnoxiaSkin experiment, we measured changes in skin blood flux on the dorsal side of both forearms 199 
with laser Doppler after each hour of exposure. Epidermal HIF-1α expression was assessed in the 200 
biopsies as described above. 201 
 202 
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Statistics 203 
Statistical analyses were performed using Statistica 8.0 (StatSoft, Tulsa, OK, USA). All data are reported 204 
as mean ± SD. Normal distribution of the data was confirmed by Shapiro-Wilks tests. Subsequently, a 205 
two-way (condition × time) general linear model repeated measures ANOVA was used to examine the 206 
differences in all variables. Mauchly's test was conducted to assess for sphericity, and the Greenhouse-207 
Geisser ε correction was used to adjust the degrees of freedom, when the assumption of sphericity was 208 
not satisfied. When ANOVA revealed significant F-ratio for interaction, pairwise comparisons were 209 
performed with Tukey honestly significant difference post hoc test to assess differences between single 210 
measurement points. The alpha level of significance was set a priori at 0.05. 211 
  212 
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Results 213 
 214 
HypoxiaSkin experiment 215 
 216 
Methodological evaluation 217 
Continuous pulse oximetry confirmed normal (~ 97 %) capillary oxyhemoglobin saturation throughout 218 
both the HypoxiaSkin and Control1 trials, hence excluding inspiration of hypoxic air during HypoxiaSkin. 219 
Subjects replied 48 times whether they believed that barometric pressure was reduced or not (three 220 
times per subject and trial). They were indecisive 38 times, guessed correctly twice and incorrectly 8 221 
times, hence confirming efficient blinding. 222 
 223 
Skin blood flux 224 
At baseline before the start of HypoxiaSkin and Control1, skin blood flux on the forearm was 137 ± 89 and 225 
123 ± 61 arbitrary units (AU; p = 0.60), whereas skin blood flux on the fingertip was 376 ± 85 and 353 ± 226 
125 AU (p = 0.74), respectively. Changes in skin blood flux from these baseline values are illustrated in 227 
figure 2; they were similar in HypoxiaSkin and Control1 for both the forearm (p = 0.67) and the fingertip (p 228 
= 0.78).  229 
 230 
Epidermal HIF-1α expression 231 
In two subjects, the biopsy obtained during HypoxiaSkin could not be analyzed due to technical problems. 232 
Epidermal HIF-1α expression in the other six subjects is illustrated in figure 3; no difference was 233 
observed between HypoxiaSkin and Control1 (p = 0.30).  234 
 235 
Circulating NO2
- 236 
13 
 
 
 
In one subject, venous NO2
- concentration considerably exceeded the expected physiological range in 237 
both conditions, and these data were hence excluded from the figure and the statistics. As illustrated in 238 
figure 4, venous NO2
- concentration remained similar throughout HypoxiaSkin and Control1 (p = 0.34) in 239 
the remaining seven subjects. 240 
 241 
Systemic response 242 
Markers of the systemic response to HypoxiaSkin and Control1 are presented in table 1. For simplicity, we 243 
only present results obtained during baseline, as well as after 10 min, 1, 4 and 8 hours of exposure. 244 
Systolic (p = 0.59) and diastolic (p = 0.62) arterial pressure, cardiac stroke volume (p = 0.69) and cardiac 245 
output (p = 0.34) remained similar throughout HypoxiaSkin and Control1. In contrast, HR was differently 246 
affected by HypoxiaSkin and Control1 (p < 0.009). The subsequent post-hoc test could, however, not 247 
identify any significant differences between single measurement points. 248 
 249 
Circulating VEGF and erythropoietin 250 
VEGF and erythropoietin concentrations measured in venous blood are summarized in table 2; both 251 
remained similar throughout exposure to HypoxiaSkin and Control1 (VEGF, p = 0.27 and erythropoietin, p 252 
= 0.76). 253 
 254 
AnoxiaSkin experiment 255 
Figure 5 illustrates the changes from baseline for forearm skin blood flux throughout AnoxiaSkin and 256 
Control2. No significant difference between AnoxiaSkin and Control2 was detected (p = 0.81). 257 
Figure 6 presents the individual responses of epidermal HIF-1α expression, where no differences were 258 
observed between AnoxiaSkin and Control2 (p = 0.90).  259 
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Discussion 260 
 261 
Our main findings are that neither a reduction in skin-surface PO2 nor the absence of O2 at the skin-262 
surface had an effect on skin blood flow, or on epidermal HIF-1α expression. Furthermore, HypoxiaSkin 263 
had no effect on NO metabolism. 264 
Our hypotheses were based on a study exposing mice with epidermis-specific knockout of the HIF-1α 265 
gene to hypoxia (Boutin et al., 2008). Comparison to wild-type mice indicated that epidermal HIF-1α 266 
expression in hypoxia facilitates initial constriction and subsequent dilation of the cutaneous 267 
vasculature. Reducing the inspired PO2, while preserving the PO2 surrounding the body, subsequently 268 
revealed that epidermal HIF-1α expression and the resulting cutaneous vasomotor responses occur as a 269 
consequence of the low PO2 on the skin-surface, rather than in the arterial blood. To test whether 270 
reductions in skin-surface PO2 exert a similar effect in humans, we first conducted the HypoxiaSkin 271 
experiment, which involved a reduction in skin-surface PO2 that may occur during normal human life. 272 
Exposure of the whole body surface to the reduced PO2 furthermore allowed investigating the systemic 273 
effects of a potential skin blood flow response. Since we observed no effect of HypoxiaSkin, we conducted 274 
the AnoxiaSkin experiment, in which the stimulus was maximized by complete removal of O2 from the 275 
skin-surface. Together, the results of the two experiments strongly contradict that the human cutaneous 276 
vasculature is responsive to reductions in skin-surface PO2. The unchanged epidermal HIF-1α expression 277 
furthermore implies that neither HypoxiaSkin nor AnoxiaSkin disturbed epidermal O2 homeostasis. This is 278 
surprising, since PO2-driven transcutaneous O2 diffusion represents the principal O2 source for epidermal 279 
cells (Stucker et al., 2002). A potential explanation could be that arterial O2 delivery replaced 280 
transcutaneous O2 diffusion during HypoxiaSkin and AnoxiaSkin. To distinguish any potential effect of a 281 
reduced skin-surface PO2 on skin blood flow from the cutaneous vasodilatory response to systemic 282 
hypoxia, we reduced the PO2 on the skin-surface while preserving arterial PO2. Accordingly, if 283 
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transcutaneous O2 diffusion decreased or even ceased during HypoxiaSkin and AnoxiaSkin, the resulting 284 
reduction in epidermal PO2 enhanced the PO2 gradient from the capillary blood, which may have 285 
accelerated O2 diffusion from the blood into the epidermis. A balance between O2 diffusion into the 286 
epidermis from the blood and from the skin-surface is supported by the observation that 287 
experimentally-induced changes in arterial O2 delivery to the skin lead to opposing changes in 288 
transcutaneous O2 diffusion (Stucker et al., 2000). In this context, the thermoneutral environment in our 289 
study could have played a role since in a cold environment thermoregulatory cutaneous 290 
vasoconstriction (Elstad et al., 2014) might have reduced arterial O2 delivery to the skin. In contrast to 291 
our study, the animals in the mouse study were breathing a hypoxic gas mixture when the PO2 on the 292 
skin-surface was manipulated (Boutin et al., 2008). The low arterial PO2 may have prevented a 293 
compensatory increase in arterial O2 extraction when transcutaneous O2 diffusion decreased, leading to 294 
more pronounced disturbance of epidermal O2 homeostasis.  295 
Taken together, our results contradict the notion that a decrease in skin-surface PO2 independently 296 
affects skin blood flow in humans. Whether the combination of a reduced PO2 in the inspired air and on 297 
the skin-surface stimulate epidermal HIF-1α expression remains to be determined, although the 298 
consequence on skin blood flow may be difficult to isolate from the cutaneous vascular response to 299 
systemic hypoxia in such a setup. 300 
The cutaneous vasomotor response to a reduction in skin-surface PO2 in mice was bipartite, consisting 301 
of vasoconstriction within the first five hours and subsequent vasodilation (Boutin et al., 2008). While 302 
the mechanism underlying the vasoconstriction remains speculative, the vasodilation was linked to 303 
stimulation of NO synthase expression in skin cells (Cowburn et al., 2013). We did not detect an effect of 304 
HypoxiaSkin on circulating NO2
-; however, since epidermal HIF-1α remained unchanged, its proposed 305 
regulatory role regarding cutaneous NO metabolism is neither supported, nor challenged. Interestingly, 306 
epidermal HIF-1α-induced stimulation of NO synthase expression and the resulting cutaneous 307 
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vasodilation in mice was associated with a reduction in arterial pressure (Boutin et al., 2008, Cowburn et 308 
al., 2013). If epidermal HIF-1α stimulates NO metabolism also in humans, a similar reduction in arterial 309 
pressure could be expected given the extensive vascularization of the human skin and the important 310 
role of NO in the regulation of cutaneous vascular tone (Clough, 1999). A negative correlation between 311 
epidermal HIF-1α expression and arterial pressure was indeed observed in humans ranging from normo- 312 
to hypertensive (Cowburn et al., 2013). These augural findings are not expanded by the present results, 313 
again, since epidermal HIF-1α was unaffected by HypoxiaSkin. Nevertheless, given the possible 314 
implication for the pathophysiology of hypertension, the potential role of epidermal HIF-1α in arterial 315 
pressure regulation deserves further attention. 316 
We acknowledge that during both HypoxiaSkin and AnoxiaSkin, the forearm skin blood flux tended to be 317 
slightly lower than in the respective Control trials. The small subject number hereby constitutes a study 318 
limitation as it provides us with insufficient statistical power to rule out a type II error. Still, even if the 319 
skin blood flux data from the two experiments are pooled, there is no significant difference between 320 
HypoxiaSkin/AnoxaSkin and Control1/Control2 (p = 0.16), and there was also no effect of HypoxiaSkin on the 321 
perfusion of the glabrous skin of the fingertip. Furthermore, none of the variables that were 322 
hypothesized to mediate the cutaneous vasomotor response to reductions in skin-surface PO2 were 323 
affected. Finally, no systemic consequences of HypoxiaSkin were observed, indicating that even if a slight 324 
cutaneous vasomotor response to reductions in skin-surface PO2 was overlooked, it would have been 325 
too minor to have notable physiological consequences. 326 
There are further limitations to this study: First, since only male subjects were included, an effect of 327 
reductions in skin surface PO2 cannot be ruled out in females. Second, due to the short half-life of NO in 328 
blood (Liu et al., 1998), we used NO2
- as marker for circulating NO. Nevertheless, NO2
- accurately reflects 329 
changes in NO synthase activity (Lauer et al., 2001) and our measurement method has both, high 330 
accuracy and precision (Nagababu and Rifkind, 2007). Third, we cannot exclude that HypoxiaSkin or 331 
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AnoxiaSkin affected a variable that was not monitored. Indeed, preliminary findings suggest that anoxia 332 
on the skin surface of humans might affect cerebral blood flow regulation and autonomic control (Pucci 333 
et al., 2012), although this remains to be confirmed with more direct measurement methods. 334 
In conclusion, the present study does not support that the skin perfusion of healthy men responds to 335 
changes in skin-surface PO2. Since neither HypoxiaSkin nor AnoxiaSkin affected epidermal HIF-1α 336 
expression, a different experimental model will have to be used to investigate whether epidermal HIF-337 
1α plays a role in the regulation of NO metabolism, skin perfusion and arterial pressure in humans. 338 
  339 
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Tables 399 
 400 
Table 1: Systemic response to HypoxiaSkin 401 
  Baseline 10 min 1 hour 4 hours 8 hours 
Systolic arterial 
pressure (mmHg) 
Control1 126 ± 15 126 ± 15 128 ± 11 133 ± 7 138 ± 7 
HypoxiaSkin 121 ± 7 128 ± 12 123 ± 8 130 ± 12 131 ± 10 
Diastolic arterial 
pressure (mmHg) 
Control1 71 ± 11 71 ± 7 72 ± 6 71 ± 3 75 ± 6 
HypoxiaSkin 70 ± 9 73 ± 9 69 ± 4 69 ± 7 71 ± 8 
Heart rate 
(beats min-1) * 
Control1 64 ± 8 59 ± 5 57 ± 4 57 ± 4 61 ± 4 
HypoxiaSkin 60 ± 8 60 ± 8 58 ± 8 58 ± 7 63 ± 7 
Stroke volume 
(ml) 
Control1 113 ± 10 114 ± 14 115 ± 13 122 ±16 111 ±13 
HypoxiaSkin 113 ± 14 110 ± 17 108 ± 17 119 ± 18 113 ±17 
Cardiac output 
(l min-1) 
Control1 7.2 ± 1.1 6.6 ± 0.7 6.6 ± 1.0 6.9 ± 1.1 6.8 ± 0.9 
HypoxiaSkin 6.7 ± 1.1 6.1 ± 1.3 6.2 ± 1.1 6.8 ± 0.9 7.1 ± 1.2 
Measurements were obtained before (Baseline), after 10 min and then after every hour of exposure. 402 
Results obtained after 2, 3, 5, 6 and 7 hours are omitted for simplicity. Values are means ± SD. *p < 0.05 403 
for comparison between the responses to Control1 and HypoxiaSkin. No significant differences between 404 
single measurement points were identified by post-hoc testing. 405 
  406 
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Table 2: Effect of HypoxiaSkin on circulating erythropoietin and vascular endothelial growth factor 407 
  Baseline 1 hour 4 hours 8 hours 
Erythropoietin 
(U l-1) 
Control1 10.9 ± 2.5 11.2 ± 2.5 11.3 ± 3.0 10.2 ± 3.3 
HypoxiaSkin 12.7 ± 4.4 13.1 ± 4.4 13.1 ± 5.7 11.3 ± 4.7 
VEGF 
(μMol l-1) 
Control1 36.6 ±13.8 45.6 ± 12.7 47.8 ± 18.8 43.4 ±15.4 
HypoxiaSkin 44.9 ± 14.9 41.4 ± 13.3 45.6 ± 11.9 41.0 ± 4.3 
Erythropoietin and vascular endothelial growth factor (VEGF) concentrations were measured in venous 408 
blood that was obtained before (Baseline) as well as after 1, 4 and 8 hours of exposure. Values are 409 
means ± SD. No significant differences were observed between the responses to Control1 and 410 
HypoxiaSkin. 411 
  412 
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Legends to figures 413 
 414 
Figure 1: Protocol of the HypoxiaSkin study. 415 
PB, barometric pressure; FiO2, O2 fraction in the inspired gas mixture; PiO2, inspired partial pressure of 416 
O2. 417 
 418 
Figure 2: Effect of HypoxiaSkin on skin blood flux. 419 
Skin blood flux was measured in arbitrary units (AU) before (Baseline, BL), after 10 min, and then after 420 
every hour of exposure on the dorsal forearm (triangles) and on the index fingertip (circles). Results are 421 
presented as changes from the BL values. Data points represent means ± SD. No significant differences 422 
were observed between Control1 and HypoxiaSkin. 423 
 424 
Figure 3: Effect of HypoxiaSkin on epidermal HIF-1α expression. 425 
HIF-1α expression was assessed by immunohistochemical staining in skin biopsies obtained from the 426 
dorsal forearm. The biopsies of two subjects could not be analysed for technical reasons and the data 427 
points illustrate the individual results for the remaining 6 subjects. Short, horizontal lines represent the 428 
average values during Control1 and HypoxiaSkin, respectively. No significant difference was observed 429 
between Control1 and HypoxiaSkin 430 
 431 
Figure 4: Effect of HypoxiaSkin on circulating NO2
-. 432 
NO2
- was measured as a marker for NO before (Baseline, BL), as well as after 1, 4 and 8 hours of 433 
exposure. Data points represent means ± SD. No significant differences were observed between Control1 434 
and HypoxiaSkin. 435 
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 436 
Figure 5: Effect of AnoxiaSkin on skin blood flux. 437 
Skin blood flux was measured in arbitrary units (AU) before (Baseline, BL), and then after every hour of 438 
exposure on the dorsal forearm. Results are presented as changes from the BL values. Data points 439 
represent means ± SD. No significant differences were observed between Control2 and AnoxiaSkin. 440 
 441 
Figure 6: Effect of AnoxiaSkin on epidermal HIF-1α expression. 442 
HIF-1α expression was assessed by immunohistochemical staining in skin biopsies obtained from the 443 
dorsal forearm. Data points illustrate individual results and short, horizontal lines represent the average 444 
values during Control2 and AnoxiaSkin, respectively. No significant difference was observed between 445 
Control2 and AnoxiaSkin. 446 
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